PROJECT DETAILS

Project Submission No. S00497
Project Title 20 MW Solar Power Project by M/s Sun Pharmaceutical Industries Limited
Project Owner (as per PSF & LOA) Sun Pharmaceutical Industries Limited
Focal Point of Project Owners*(FP)
Sun Pharmaceutical Industries Limited
Email of Contact Person of FP (Primary) jibanananda.mohapatra@sunpharma.com
Email of Contact Person of FP (Secondary) rajendra.gadhe@sunpharma.com
Country India
Submission Date 28 Jun 2022
Global Stakeholder Consultation Period 10 Oct 2022 - 24 Oct 2022
Sector 1.Energy industries (renewable-/non-renewable sources)
GCC/CDM Methodology & Version GCCM001 Methodology for Renewable Energy Generation Projects Supplying Electricity to Grid or Captive Consumers & version 3.0
Forecasted GHG Emission Reduction(TCO2/Year) 29,941
Forecasted E+ Label Yes
Forecasted S+ Label Yes
Forecasted SDG+ Goals 5,7,8,13
Forecasted SDG+ Label Gold
Forecasted Market Eligibility CORSIA(C+)
Name of Authorized External Representative Organization
Name of Focal Point of External Representative
Email-id of Focal Point
Documents for Global Stakeholder Consultation Project Submision, Calculation Sheet, Other Documents
Project Brief

The project activity is the installation of a new captive grid-connected 20 MW Solar power plant at the site where no renewable power plant was operating prior to the implementation of the project activity (green-field plant). The project activity is solar power project which is being implemented by M/s Sun Pharmaceutical Industries Limited. The annual average estimated emission reductions from project activity are 29,941 tCO2e/annum.

Additional Information